These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3880786)

  • 1. Heterogeneity and specificity of human anti-insulin antibodies determined by isoelectric focusing.
    Thomas JW; Virta VJ; Nell LJ
    J Immunol; 1985 Feb; 134(2):1048-52. PubMed ID: 3880786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-specific murine antibodies of limited heterogeneity. I. Genetic control of spectrotypes.
    Kapp JA; Strayer DS; Robbins PF; Perlmutter RM
    J Immunol; 1979 Jul; 123(1):109-14. PubMed ID: 448141
    [No Abstract]   [Full Text] [Related]  

  • 3. Human insulin autoantibody fine specificity and H and L chain use.
    Nell LJ; Hulbert C; Thomas JW
    J Immunol; 1989 May; 142(9):3063-9. PubMed ID: 2468712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation.
    Glimcher LH; Schroer JA; Chan C; Shevach EM
    J Immunol; 1983 Dec; 131(6):2868-74. PubMed ID: 6196405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonotypes of anti-phosphocholine antibodies induced with Proteus morganii (Potter). II. Heterogeneity, class, and idiotypic analyses of the repertoires in BALB/c and A/HeJ mice.
    Williams KR; Claflin JL
    J Immunol; 1982 Feb; 128(2):600-7. PubMed ID: 7054290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of human insulin in vitro by T cells from subjects treated with animal insulins.
    Nell LJ; Virta VJ; Thomas JW
    J Clin Invest; 1985 Dec; 76(6):2070-7. PubMed ID: 2416775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG antibodies to secretory component in normal human serum.
    Splawski JB; Woodard CS; Denney RM; Goldblum RM
    J Immunol; 1984 Oct; 133(4):2111-5. PubMed ID: 6332148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of two Dermatophagoides pteronyssinus-specific epitopes on antigen P1 by using monoclonal antibodies: binding to each epitope can be inhibited by serum from dust mite-allergic patients.
    Chapman MD; Sutherland WM; Platts-Mills TA
    J Immunol; 1984 Nov; 133(5):2488-95. PubMed ID: 6207232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hapten-specific B cell repertoire probed by hybridoma technology: selection and characterization of representative clonotypes from the antibody-forming cell pool.
    Bloor AG; Jou Y; Hoeplinger C; Gartner JE; Mayers GL; Bankert RB
    J Immunol; 1982 Mar; 128(3):1443-9. PubMed ID: 6173438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subpopulations of antibodies directed against evolutionarily conserved regions of the insulin molecule in insulin-treated patients.
    Karlsson F; Harrison LC; Kahn CR; Itin A; Roth J
    Diabetologia; 1982 Dec; 23(6):488-93. PubMed ID: 6759274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human immune response to insulin. I. Kinetic and cellular aspects of lymphocyte proliferative responses in diabetics.
    Nell LJ; Thomas JW
    J Immunol; 1983 Aug; 131(2):701-5. PubMed ID: 6190938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
    J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE and IgG antibody against human (recombinant DNA) insulin in patients with systemic insulin allergy.
    Grammer LC; Roberts M; Patterson R
    J Lab Clin Med; 1985 Jan; 105(1):108-13. PubMed ID: 3881543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
    Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
    Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human insulin.
    Raptis S; Dimitriadis G
    Clin Physiol Biochem; 1985; 3(1):29-42. PubMed ID: 3888492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a rapid enzyme-linked immunosorbent microassay (ELISA) to study human anti-insulin antibody.
    Nell LJ; Virta VJ; Thomas JW
    Diabetes; 1985 Jan; 34(1):60-6. PubMed ID: 3880549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte proliferation as a test of the immune response to insulin in diabetics.
    Kurtz AB; Di Silvio L; Lydyard P
    Diabetes Res; 1985 Jul; 2(4):175-8. PubMed ID: 3910325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of insulin antibodies.
    Kansal PC; Bandisode MS; Boshell BR
    Horm Metab Res; 1979 Mar; 11(3):187-9. PubMed ID: 447197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.